The Alldus Podcast - AI in Action

Today's guest is Semih Korkmaz, Co-Founder at Stoovo in San Francisco. Founded in 2018, Stoovo believe you should never be limited when it comes to opportunities. Everyone deserves to be in control of their finances and the way they work. That's why the Stoovo app empowers people to work and earn on their own terms. In the episode, Semih will discuss: The origins & current work they do at Stoovo, An insight into the problems they are solving for customers, The role of AI and it’s impact in the business, Current projects the team are working on, Plans for growth and what the future holds, and What he learned from building a startup

Today's guest is Ben Tengelsen,  VP of Data Science at IntelyCare in Greater Boston, MA. Founded in 2014, IntelyCare are the leading tech-enabled nurse staffing platform for healthcare organizations in the U.S. Through their AI-based platform, they schedule and match nursing professionals with open assignments at 1,600+ organizations across the country. In doing so, they provide nurses and nursing assistants with unprecedented flexibility in their work lives, while at the same time empowering healthcare organizations to take control of how they manage nursing staff. Ben leads a team of data scientists and analysts in their mission to generate as much value as possible from IntelyCare's data. They are experts at statistical and predictive modeling, but are also fullstack engineers when it comes to scaling and deploying models. Projects include a state-of-the-art pricing algorithm (AI based, learns in real time), a powerful recommendation engine (used for both in-app recommendations and targeted messaging), and various forecasting algorithms to manage things like on-call pools, engagement campaigns and last-minute requests. In the episode, Ben will discuss: The work IntelyCare do helping nurses, How they use data at IntelyCare, The role of Machine Learning & Data Science within the platform, What it’s like to be part of the Data Science team, The impact of Covid-19 within the business, and Plans for growth & what the future holds for IntelyCare

Today's guest is Erik Duhaime, Co-Founder and CEO at Centaur Labs in Boston, MA. Founded in 2017, Centaur Labs offers medical data labeling (classification, segmentation etc.) from a network of medical experts. Instead of having to choose between the high cost of hiring physicians or the low quality of crowdsourced/blended teams, they offer an alternative that leverages collective intelligence and performance based incentives. Centaur Labs' technology - developed by researchers at MIT - collects multiple opinions per case with labelers competing against each other for cash rewards. This process ensures that quality assurance is baked into the process since the labelers are incentivized to perform at the highest level on every case analyzed. Centaur Labs offers industry leading accuracy, affordable pricing and very low management overhead on the part of the client since all engagements include a dedicated customer success manager. In the episode, Erik will discuss: Their mission to annotate the world’s medical data, Early challenges and the journey of building the company, Use cases of the benefits they bring to customers, Combining AI with the user experience, An insight into the team and working culture, and What the future holds for Centaur Labs.  To find out more, check out the website www.centaurlabs.com

Today's guest is Andrew Konya, CEO at Remesh in New York. Remesh was founded in 2014 with the mission to create a technology that could truly represent the will of the people and amplify their collective voice. As a company, they believe in the power of helping people understand one another, which requires engaging, exchanging ideas, and having a dialogue with groups of people at a massive scale. Remesh believe that conversations that bridge cultural, political, social, economic and geographic divides ultimately lead to a more unified and less divided world. Remesh's platform leverages AI to analyze the opinions and interactions of up to 1,000 participants in real-time and helps understand the responses that best represent the group, all in a matter of minutes. You can discover trends and themes that were most common with your audience, compare and contrast responses between audience segments, and export all of your data in just one click. Customers across many industries use Remesh to better understand their audience, enabling them to make better products, companies and governments. In the episode, Andrew will discuss: The origins and current work he does with Remesh, How the company has evolved over the past nine years, Use cases of the benefits they bring to customers, The role of AI & ML in their platform, Plans for growing the team, and  What excites him for the future at Remesh

Today's guest is Christopher Li, Co-Founder and CEO at BioBox Analytics in Toronto, Canada. As their understanding of life sciences grow, so does the scope of research. Legacy software was built to tackle challenges that now represents a small fraction of modern research needs. BioBox is revolutionizing the way they do research by creating the world’s most intelligent and intuitive data analytics platform for modern scientists. Scientific breakthroughs are often just around the corner, but when the tools are scattered all over the place, they can be missed. BioBox was designed to provide scientists with all the tools they need along their journey all in one place. BioBox is a platform that manages your data and your research computing infrastructure, which means you spend less time looking for data and setting things up, and more time for your research. In the episode, Christopher will discuss: The journey to founding BioBox Analytics, Their mission and challenges they are solving within scientific research, The role of Data & Machine Learning in the BioBox platform, The current make-up of the engineering team, Plans for further growth and upcoming projects, and The impact BioBox Analytics are making in the industry

Today's guest is Mehrshad Setayesh, CTO at NextHealth Technologies in Denver, Colorado. NextHealth Technologies is demystifying the most complicated industry in the land: the American healthcare system. They empower decision makers  to cut through the complexity and get to better decisions faster, and ultimately do what everybody needs: make healthcare more affordable. Health plan leadership - from the C-suite, to program managers, to critical initiatives champions - all stand to benefit from NextHealth Technologies. Together, they will identify which members to engage and how to reach them. Through personalized outreach and analytics, they can predict who’ll enroll, participate and stick with each program. In the episode, Mehrshad will discuss: The interesting work he does with NextHealth, How the tech & data team is structured for success, Use cases of the AI & ML projects they deliver for customers, The success they’ve enjoyed in the past couple of years, Plans for growing the team, and What excites him for the future at Nexthealth

Today's guest is Jay Nanduri, Chief Technical Officer at Truveta in Seattle. Founded in 2020, Truveta's aim is to enable researchers to find cures faster, empower every clinician to be an expert and help families make the most informed decisions about their care. Clinical data from their members is de-identified daily and brought together in an unprecedented data platform to enable research on all health conditions. Truveta believe their collective de-identified data can be used to accelerate research, advance health equity and save lives. Jay is a former Microsoft Technical Fellow with over twenty years of experience, 25+ patents and several publications that demonstrate exemplary technical and business leadership. He has a proven track record of managing and delivering mission critical projects from conception to delivery. Jay also has extensive hands-on experience in designing highly scalable distributed systems, big data, big graph, secure internet platforms, fraud prevention, BI analytics, Ecommerce, personalization, workflow systems and Machine Learning/AI platforms. In the episode, Jay will discuss: His background and previous experience with Microsoft, What motivated him to move to Truveta, The work they do at Truveta and defining their mission statement, Their focus on data coverage, data quality, data consumption and community, Using AI for the benefit of health systems, researchers and clinicians, Using Healthcare Data responsibly and Career opportunities within AI in Healthcare

Today's guest is Adam Gotlin, Head of Business Analytics at Kaia Health in New York. Founded in 2016, Kaia Health is a leading digital therapeutics company that creates evidence-based treatments for a range of disorders including musculoskeletal conditions and COPD. Kaia Health uses innovative technology such as AI and Computer Vision, and works with medical experts to create an interdisciplinary digital approach. This empowers and motivates individuals to take control and self-manage their condition with effective, non-pharmacological, digital alternatives at low costs. In the episode, Adam will talk about: The work they do at Kaia Health in home rehabilitation care, The role of AI in their platform, Creating the best user experience for customers, The impact of Covid-19 on the business, How the tech team is set up for success, The culture and what it is like to work at Kaia Health & What the future holds for the company

Today's guest is Jason Christiansen, Chief Technology Officer at Epic Sciences in San Diego. Founded in 2008, Epic Sciences is developing novel diagnostics to personalize and advance the treatment and management of cancer. Epic’s mission is to enable the rapid and non-invasive detection of genetic and molecular changes in cancer throughout a patient’s journey. The company was founded on a powerful platform to identify and characterize rare cells, including circulating tumor cells (CTCs). Epic's technology helps match patients to targeted therapies and monitor for drug resistance, so that the best treatment path can be chosen at every clinical decision point. Today, they partner with leading pharmaceutical companies and major cancer centers around the world. Their goal is to commercialize our technology to increase the success rate of cancer drugs in clinical trials and improve patient outcomes by providing physicians with real-time information to guide treatment choices. In the episode, Jason will discuss: The work he is doing with Epic Sciences, Current projects the data science team are working on, Use cases of the impact their products bring to the industry, What the future holds for Epic Sciences & How they attract top talent to join the team

Today's guest is Meghan Gaffney, Founder and CEO at VEDA Data Solutions. Founded in 2015, Veda are on a mission to accelerate patients’ ability to access the care they need, reduce financial loss in the healthcare system and create efficiencies that drive healthcare innovation. They are motivated by a belief that the tools to make a better world are being developed right now by talented scientists around the globe and they can harness those tools to solve the problems impacting people every day. Today, over 15 million people rely on Veda's tools to power the healthcare industry. Meghan provides resources and strategic leadership to our employees and serves as a liaison to their customers and partners. With over 15 years of experience working with federal and state elected officials and consulting on technology opportunities, she has experience helping people– from elected leaders to impact organizations– achieve their goals. She is a passionate advocate for AI and Machine Learning, and believes it will create unprecedented economic opportunity for the United States and the world. In the episode, Meghan will discuss: The motivation for founding Veda, Getting her idea off the ground from a technical perspective, The current make-up of the team, Use cases of the impact that Veda brings to customers, Interesting projects the Tech and Data team are working on, The importance of diversity and inclusion, and  What excites her for the future at Veda